NASDAQ: ALXN       Alexion Pharm Inc
Last Price Today's Change   Day's Range   Trading Volume
114.68   -3.53 (2.99%)  113.235 - 119.93  781,319


Avg Volume (4 weeks):2,400,675
4 Weeks Range:110.40 - 128.57
4 Weeks Price Volatility (%):
52 Weeks Range:72.67 - 128.57
52 Weeks Price Volatility (%):
Average Price Target: 208.00
Price Target Upside/Downside: +93.32


No recent Headlines for this stock.

Business Background

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1882  4059  316  3139 

Top 10 Active Counters
 BLRX 2.609+1.129 
 LK 1.38+1.38 
 AAPL 108.53-6.79 
 NIO 30.705-1.285 
 SQQQ 25.40+2.04 
 OAS 0.155-0.014 
 TWTR 41.516-10.914 
 GE 7.375+0.005 
 HTZ 1.780.00 
 NOK 3.355+0.005